Clinical Trials Directory

Trials / Completed

CompletedNCT07050017

Impact of Protein Content of Milk on Post-Exercise Appetite and Energy Intake

High Milk Protein Content Reduces ad Libitum Post-exercise Energy Intake Without Altering Appetite in Active Males

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
16 (actual)
Sponsor
Hacettepe University · Academic / Other
Sex
Male
Age
18 Years – 39 Years
Healthy volunteers
Accepted

Summary

This study aims to investigate the acute effects of consuming milk beverages with different protein content on subjective appetite and energy intake in healthy adults following endurance exercise. Participants will complete an endurance exercise protocol and then consume one of three beverages: a high-protein milk, a regular-protein milk, or an isoenergetic and isovolumetric carbohydrate control drink. Subjective appetite ratings will be assessed using visual analogue scales (VAS) at multiple time points after beverage consumption. Appetite-related hormonal responses, including insulin and acylated ghrelin, will be measured via blood samples. Energy intake will be assessed through an ad libitum test meal. This study will help determine whether different types of milk consumed post-exercise influence appetite regulation, hormonal response, and subsequent energy intake.

Detailed description

The primary objective of this randomized, double-blind, crossover clinical trial is to evaluate the acute effects of post-endurance exercise consumption of milk beverages with varying protein content on subjective appetite, circulating appetite-related hormones, and subsequent ad libitum energy intake in healthy, recreationally active adult males. The study will recruit at least 12 healthy male participants aged 18-39 years who have been regularly engaged in endurance-based physical activity (e.g., cycling, running, triathlon, orienteering, team sports) for a minimum of one year, with a training frequency of at least three sessions per week lasting 60-90 minutes each. Participants will complete five laboratory visits under a crossover design with a minimum one-week washout period between intervention conditions. The first two sessions will consist of pre-study visits (screening, anthropometric assessments, VO₂max testing, and familiarization). The remaining three visits will involve the ingestion of one of the following beverages in a randomized order: standard-protein milk (0 g protein), high-protein milk (30 g protein), or an isoenergetic carbohydrate-based control beverage (0 g protein). All beverages will be isocaloric and isovolumetric and provided in opaque bottles to ensure double-blind conditions. On each intervention day, participants will perform a steady-state endurance exercise protocol using a calibrated cycle ergometer, followed immediately by the ingestion of one of the test beverages. Appetite will be assessed subjectively using validated Visual Analogue Scales (VAS) at predefined intervals. Venous blood samples will be collected to analyze concentrations of insulin and acylated ghrelin as objective biomarkers of appetite regulation. One hour after beverage consumption, an ad libitum test meal will be provided to quantify subsequent energy intake. The total caloric intake and macronutrient distribution will be recorded and analyzed. This study is designed to provide insight into the role of post-exercise milk consumption-specifically the influence of protein content-on short-term appetite modulation and energy intake regulation in recreationally trained individuals.

Conditions

Interventions

TypeNameDescription
BEHAVIORALThe study will investigate how different amounts of protein (0 g, 15 g, and 30 g) in post-exercise beverages affect appetite and energy intake following endurance exercise.The study will investigate how different amounts of protein (carbohydrate control drink : 0 g, reguler milk : 15 g, and high-protein milk : 30 g) in post-exercise beverages affect appetite and energy intake following endurance exercise.

Timeline

Start date
2025-05-29
Primary completion
2025-07-29
Completion
2025-09-29
First posted
2025-07-03
Last updated
2025-10-06

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT07050017. Inclusion in this directory is not an endorsement.